Kenneth W. Harder

3.4k total citations
49 papers, 2.9k citations indexed

About

Kenneth W. Harder is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Kenneth W. Harder has authored 49 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 26 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Kenneth W. Harder's work include Immune Cell Function and Interaction (18 papers), T-cell and B-cell Immunology (12 papers) and Protein Tyrosine Phosphatases (11 papers). Kenneth W. Harder is often cited by papers focused on Immune Cell Function and Interaction (18 papers), T-cell and B-cell Immunology (12 papers) and Protein Tyrosine Phosphatases (11 papers). Kenneth W. Harder collaborates with scholars based in Canada, Australia and United States. Kenneth W. Harder's co-authors include Margaret L. Hibbs, David M. Tarlinton, Frank R. Jirik, Yuekang Xu, Nicholas D. Huntington, Nicole Kountouri, Ian Clark‐Lewis, Cathy Quilici, Ruedi Aebersold and Ashley R. Dunn and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Blood.

In The Last Decade

Kenneth W. Harder

49 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenneth W. Harder Canada 26 1.5k 1.4k 504 241 229 49 2.9k
Esteban S. Masuda United States 33 1.2k 0.8× 1.2k 0.8× 384 0.8× 235 1.0× 206 0.9× 78 2.6k
Joanna M. Woodcock Australia 32 1.3k 0.9× 1.4k 1.0× 681 1.4× 367 1.5× 112 0.5× 65 3.1k
Robert B. Henderson United Kingdom 21 924 0.6× 1.1k 0.8× 277 0.5× 233 1.0× 143 0.6× 42 2.6k
Navin Rao United States 24 1.3k 0.9× 1.1k 0.8× 558 1.1× 234 1.0× 159 0.7× 43 2.9k
Anne L. Burkhardt United States 28 1.1k 0.8× 1.7k 1.2× 930 1.8× 200 0.8× 351 1.5× 51 3.5k
J. Michael McDaniel United States 23 1.5k 1.0× 1.1k 0.8× 537 1.1× 130 0.5× 143 0.6× 29 2.8k
Charles Perkins United States 22 1.2k 0.8× 753 0.5× 399 0.8× 279 1.2× 289 1.3× 35 2.7k
Elias Hobeika Germany 27 1.2k 0.8× 2.1k 1.5× 363 0.7× 147 0.6× 241 1.1× 49 3.3k
Hal Blumberg United States 17 1.0k 0.7× 1.4k 1.0× 352 0.7× 149 0.6× 112 0.5× 18 2.6k
Pavla Angelisová Czechia 24 1.0k 0.7× 1.3k 0.9× 200 0.4× 167 0.7× 74 0.3× 46 2.3k

Countries citing papers authored by Kenneth W. Harder

Since Specialization
Citations

This map shows the geographic impact of Kenneth W. Harder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth W. Harder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth W. Harder more than expected).

Fields of papers citing papers by Kenneth W. Harder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth W. Harder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth W. Harder. The network helps show where Kenneth W. Harder may publish in the future.

Co-authorship network of co-authors of Kenneth W. Harder

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth W. Harder. A scholar is included among the top collaborators of Kenneth W. Harder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth W. Harder. Kenneth W. Harder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robertson, A. Gordon, Iva Kulić, Yu‐Hsuan Huang, et al.. (2023). Tumor-derived GCSF Alters Tumor and Systemic Immune System Cell Subset Composition and Signaling. Cancer Research Communications. 3(3). 404–419. 3 indexed citations
2.
Harder, Kenneth W., et al.. (2022). An End-to-End Workflow for Interrogating Tumor-Infiltrating Myeloid Cells Using Mass Cytometry. Methods in molecular biology. 2508. 147–168. 1 indexed citations
3.
Thaper, Daksh, Sepideh Vahid, Ka Mun Nip, et al.. (2017). Targeting Lyn regulates Snail family shuttling and inhibits metastasis. Oncogene. 36(28). 3964–3975. 30 indexed citations
4.
Priatel, John J., et al.. (2014). SLAM-associated protein modulates CD8 T cell responses primed by antigen-presenting B cells (IRM4P.503). The Journal of Immunology. 192(Supplement_1). 61.10–61.10. 1 indexed citations
5.
Roberts, Morgan E., Brad H. Nelson, Jolanta Grembecka, et al.. (2013). Dysregulated Hematopoiesis Caused by Mammary Cancer Is Associated with Epigenetic Changes and Hox Gene Expression in Hematopoietic Cells. Cancer Research. 73(19). 5892–5904. 42 indexed citations
6.
Nijnik, Anastasia, Jelena Pistolic, Patricia Cho, et al.. (2012). The role of the Src family kinase Lyn in the immunomodulatory activities of cathelicidin peptide LL-37 on monocytic cells. Journal of Leukocyte Biology. 91(4). 599–607. 3 indexed citations
7.
Shio, Marina Tiemi, Stephanie C. Eisenbarth, Adrien F. Vinet, et al.. (2009). Correction: Malarial Hemozoin Activates the NLRP3 Inflammasome through Lyn and Syk Kinases. PLoS Pathogens. 5(9). 63 indexed citations
8.
Priatel, John J., Xiaoxi Chen, Lauren A. Zenewicz, et al.. (2007). Chronic Immunodeficiency in Mice Lacking RasGRP1 Results in CD4 T Cell Immune Activation and Exhaustion. The Journal of Immunology. 179(4). 2143–2152. 27 indexed citations
9.
McColl, Bradley, Karri Paavonen, Tara Karnezis, et al.. (2007). Proprotein convertases promote processing of VEGF‐D, a critical step for binding the angiogenic receptor VEGFR‐2. The FASEB Journal. 21(4). 1088–1098. 92 indexed citations
10.
Hibbs, Margaret L. & Kenneth W. Harder. (2006). The duplicitous nature of the Lyn tyrosine kinase in growth factor signaling. Growth Factors. 24(2). 137–149. 33 indexed citations
11.
Ingley, Evan, Christine J. Payne, David J. McCarthy, et al.. (2006). Csk-binding Protein Mediates Sequential Enzymatic Down-regulation and Degradation of Lyn in Erythropoietin-stimulated Cells. Journal of Biological Chemistry. 281(42). 31920–31929. 38 indexed citations
12.
Ingley, Evan, Christine J. Payne, David J. McCarthy, et al.. (2006). Csk-binding Protein Mediates Sequential Enzymatic Down-regulation and Degradation of Lyn in Erythropoietin-stimulated Cells. Journal of Biological Chemistry. 281(42). 31920–31929. 17 indexed citations
13.
Harder, Kenneth W., Joanna Kemp, Jessica Jones, et al.. (2005). Lyn-Deficient Mice Develop Severe, Persistent Asthma: Lyn Is a Critical Negative Regulator of Th2 Immunity. The Journal of Immunology. 175(3). 1867–1875. 69 indexed citations
14.
Harder, Kenneth W., Niels Peter Hundahl Møller, James W. Peacock, & Frank R. Jirik. (1998). Protein-tyrosine Phosphatase α Regulates Src Family Kinases and Alters Cell-Substratum Adhesion. Journal of Biological Chemistry. 273(48). 31890–31900. 117 indexed citations
15.
Harder, Kenneth W., et al.. (1995). Non-radioactive method to measure CD45 protein tyrosine phosphatase activity isolated directly from cells. Journal of Immunological Methods. 179(2). 177–185. 24 indexed citations
16.
Dechert, Ute, Michael Affolter, Kenneth W. Harder, et al.. (1995). Comparison of the Specificity of Bacterially Expressed Cytoplasmic Protein‐Tyrosine Phosphatases SHP and SH‐PTP2 Towards Synthetic Phosphopeptide Substrates. European Journal of Biochemistry. 231(3). 673–681. 28 indexed citations
17.
Amankwa, Lawrence N., Kenneth W. Harder, Frank R. Jirik, & Ruedi Aebersold. (1995). High‐sensitivity determination of tyrosine‐phosphorylated peptides by on‐line enzyme reactor and electrospray ionization mass spectrometry. Protein Science. 4(1). 113–125. 51 indexed citations
18.
Dechert, Ute, Michael Affolter, Kenneth W. Harder, et al.. (1995). Comparison of the Specificity of Bacterially Expressed Cytoplasmic Protein-Tyrosine Phosphatases SHP and SH-PTP2 Towards Synthetic Phosphopeptide Substrates. European Journal of Biochemistry. 231(3). 673–681. 1 indexed citations
19.
Roberge, Michel, et al.. (1994). Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A.. PubMed. 54(23). 6115–21. 82 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esteban S. Masuda Breakdown of academic impact, for papers by Joanna M. Woodcock Breakdown of academic impact, for papers by Robert B. Henderson Breakdown of academic impact, for papers by Navin Rao Breakdown of academic impact, for papers by Anne L. Burkhardt Breakdown of academic impact, for papers by J. Michael McDaniel Breakdown of academic impact, for papers by Charles Perkins Breakdown of academic impact, for papers by Elias Hobeika Breakdown of academic impact, for papers by Hal Blumberg Breakdown of academic impact, for papers by Pavla Angelisová
Rankless by CCL
2026